HealthTech

ApexAnalytics

ApexAnalytics Raises $200M Growth to Transform HealthTech

$200M Growth
Total Raised
Growth
Latest Round
2019
Founded
250-500
Employees
Chicago, IL
1 min read

Quick Facts

Valuation
$10B
Latest Round Size
$200M Growth
Latest Round Date
October 2025

ApexAnalytics Raises $200M Growth in Latest Funding Round

ApexAnalytics has successfully closed a $200M Growth funding round, marking a significant milestone in the company's growth trajectory. The round was led by Greylock Partners, with participation from Tiger Global.

Company Overview

Founded in 2019 and headquartered in Chicago, IL, ApexAnalytics has established itself in the HealthTech space. Leading clinical decision support system enhancing medical accuracy with AI

With a current valuation of $10B, the company has demonstrated strong market traction and investor confidence.

Investment Details

  • Amount Raised: $200M Growth
  • Valuation: $10B
  • Lead Investor: Greylock Partners

Future Outlook

As ApexAnalytics moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the healthtech space.

Key Investors

Greylock Partners
Venture Capital
Leading venture capital firm investing in technology companies
Tiger Global
Venture Capital
Leading venture capital firm investing in technology companies

About the Author

Michael Torres
Michael Torres
Former startup founder turned investment analyst, focusing on early-stage technology and consumer companies.